The global Fecal Calprotectin Test market is estimated to be valued at US$ 140.61 Million In 2023 and is expected to exhibit a CAGR Of 10.8% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Fecal calprotectin test is a noninvasive diagnostic tool for assessing the severity of intestinal inflammation. It measures the levels of calprotectin, a protein found in high ... Read more

Fecal calprotectin testing has emerged as a reliable non-invasive tool for diagnosing and monitoring inflammatory bowel diseases like Crohn's disease and ulcerative colitis. Fecal calprotectin is a protein released from the immune cells in the intestinal tract during inflammatory conditions. Calprotectin levels in the stool help determine the presence, severity, and extent of inflammation. Advantages of fecal calprotectin testing over other diagnostic tests include ease of sample collection ... Read more

The global fecal calprotectin test market is estimated to be valued at US$ 161.98 Mn in 2024 and is expected to exhibit a CAGR of 3.9% over the forecast period 2024 to 2030.

Fecal calprotectin tests are non-invasive screening tests used to detect inflammatory bowel disease (IBD) in patients experiencing gastrointestinal symptoms. Calprotectin is a protein found in the cytoplasm of neutrophils that is released during inflammation ... Read more